Article
Blue light-filtering IOL option for cataract surgery
Anaheim, CA-Although longer follow-up is needed to determine whether the pseu-dophakic, blue light-filter-ing IOL (AcrySof Natural, Alcon) reduces the risk of progression of age-related macular degeneration (AMD), available indirect evidence provides sufficient sup-port to advocate its use in cataract surgery, said Robert J. Cionni, MD.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
